US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist

8.640
-0.100-1.14%

Close Mar 28 16:00 ET

8.640
0.0000.00%

Post 16:05 ET

159.76MMarket Cap-7.85P/E (TTM)

OptimizeRx Stock Forum

102171590

Mar 12 21:57

$OptimizeRx (OPRX.US)$ Net loss, this company never make any profits?

Zachary Lengfield

Mar 12 21:49

$OptimizeRx (OPRX.US)$ 10$

Teddy123

Mar 12 19:37

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

$OptimizeRx (OPRX.US)$
OptimizeRx Doubles Enterprise Deals, Projects $100M Revenue as Subscription Model Takes Off

MARKET-TEST-DUMMY

Dec 7, 2024 21:49

👀

$OptimizeRx (OPRX.US)$

Jaguar8

Sep 10, 2024 20:09

NEWS

$OptimizeRx (OPRX.US)$
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing ...

Moomoo AI

Mar 15, 2024 20:14

Recent insider selling at OptimizeRx, especially by Marion Odence-Ford, may worry potential investors. The absence of insider buying and insignificant share ownership by insiders hint at possible doubts about future performance.

OptimizeRx's Stock Sinks To US$12.92, But Insiders Sold Even Lower

Moomoo AI

Dec 21, 2023 20:04

OptimizeRx's high P/S ratio may suggest that investors anticipate a turnaround in the company's revenue performance. This could indicate shareholders' strong future revenue expectations.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 20:01

The high P/S ratio at OptimizeRx suggests investors expect a reversal of the company's downtrend in revenue. Shareholders seem to hold stocks with hope for the company's promising future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 20:01

Investors at OptimizeRx might be anticipating a reversal in its poor revenue performance, hence the high P/S ratio. Shareholders potentially retain stocks expecting the company's bright future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 19:54

Investors at OptimizeRx may be expecting a turnaround in the company's poor revenue performance, hence the high P/S ratio. This could reflect shareholders' strong future revenue expectations.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%